Forecast & Rating3 analysts currently cover Takeda Pharmaceutical Company, of which 3 give a positive rating. The average price target is $21.01, about 22.4% upside from the current price of $17.17. Coverage is limited, so the data is for reference only. Data as of Jul 21, 2026; this does not constitute investment advice.
Jul 20, 2026
Price forecast
$21.0122.26%
Forecast & RatingStrong buy
3analysts
Strong buy100.00%
Buy0.00%
Hold0.00%
Sell0.00%
Strong sell0.00%
Strong buy
3
Buy
0
Hold
0
Sell
0
Strong sell
0
Target price forecast
Forecast baselineJul 26, 2026
Forecast met34.1%
Stock price$17.17
Average forecast price$17.9
Highest forecast price$19
Lowest forecast price$17
Average forecast price
$17.9
Highest forecast price
$19
Lowest forecast price
$17
Analyst ratings
Strong buy
Buy
Hold
Sell
Strong sell
Source: S&P Global
This information is for reference only and is not investment advice.